SymBio Pharmaceuticals Limited
Notice Regarding the Monthly Exercise Status of the 70th and 71st Stock Acquisition Rights Issued by Third-Party Allotment (with Exercise Price Adjustment Clause)
Published the monthly exercise status for September 2026 of the 70th and 71st stock acquisition rights. Number of shares granted: 4,300,000 shares; number of rights actually exercised in September: 43,000; ratio to total issued: 9.0%; unexercised rights: 437,000; exercise restriction: 5.4% (based on listing rules).
Key Figures
- Number of shares granted: 4,300,000 shares
- Number of stock acquisition rights exercised: 43,000 items
- Number of unexercised stock acquisition rights: 437,000 items
AI要約
Overview of Exercise Status of Stock Acquisition Rights
Impact and Background
For details on the operation of stock acquisition rights with an exercise price adjustment clause, refer to the notice related to the unsecured bond facility agreement. The monthly exercise ratio, as an indicator of potential dilution risk to the market, has generally remained low. Meanwhile, the rights allocated to the EVO FUND have special restrictions, and future exercise trends may vary depending on contractual conditions and timing of instructions.
SymBio Pharmaceuticals Limited
Company overview · Stock price · Financial data · All IR
